Searchable abstracts of presentations at key conferences in endocrinology

ea0056p319 | Clinical case reports - Thyroid/Others | ECE2018

Factitious hypoglycemia; Case report

Arikan Durmaz Senay , Gungunes Askin , Yalcin Selim

Introduction: Hypoglycemia is defined as a reduction in plasma glucose concentration to a level that may induce symptoms such as sweating, shaking, palpitation, headache, blurry vision, loss of consciousness, seizure, coma. We present a case with hypoglycemia which is due to the use of exogenous insulin.Case presentation: A 72-years-old patient with Alzheimer disease who was admitted to the emergency clinic because of unconscio...

ea0056p612 | Thyroid cancer | ECE2018

A case of diabetic patient with recurrent ketosis after U-300 glargine treatment

Ulasli Tugce , Gungunes Askin , Durmaz Senay Arikan

Introduction: U-300 glargine is a new generation long acting insulin. Nocturnal hypoglicemia and weight gain with U-300 glargine is lower than U-100 glargine. However, it may take 3–4 days for U-300 glargine to reach stable state in plasma. We report a diabetic case with recurrent ketosis after U-300 glargine.Case presentation: A 20 years old woman with type 1 diabetes mellitus who uses basal and bolus insulin (U-300 glargine and insülin aspart...

ea0041ep645 | Endocrine tumours and neoplasia | ECE2016

Postprandial hypoglycemia in the presence of insulinoma – case report

Gungunes Askin , Arikan Durmaz Senay , Oguz Dilek , Rendeci Serkan

Background and aim: Although insulinoma typically causes fasting hypoglycemia, postprandial hypoglycemia occasionally reported in these patients. We aimed to report a rare case of insulinoma who atmitted to outpatient clinic with postprandial hypoglycemia.Case report: A 31-year-old woman was admitted to outpatient clinic with postprandial hypoglycemia. Capillary blood glucose levels were found 25 and 27 mg /dl during typical hypoglycemic symptoms such as...

ea0049ep529 | Diabetes complications | ECE2017

A rare presentation of diabetic ketoacidosis: Rhino-orbito-cerebral mucormycosis

Gungunes Askin , Durmaz Senay Arikan , Yalcin Selim , Cifci Aydin , Burulday Veysel , Carlioglu Ayse

Aim and objective: Mucormycosis is a rare life-threatening fungal infection. Immunocompromised patients are often affected. We report a rare diabetic patient with pancreatic adenocarcinoma who was presented diabetic ketoacidosis and rhino-orbito-cerebral mucormycosis.Case presentation: A 66 years old man with pancreatic adenocarcinoma and type 2 diabetes mellitus was presented diabetic ketoacidosis and severe infection of the facial sinuses, orbita, and ...

ea0049ep529 (1) | Diabetes complications | ECE2017

A rare presentation of diabetic ketoacidosis: Rhino-orbito-cerebral mucormycosis

Gungunes Askin , Durmaz Senay Arikan , Yalcin Selim , Cifci Aydin , Burulday Veysel , Carlioglu Ayse

Aim and objective: Mucormycosis is a rare life-threatening fungal infection. Immunocompromised patients are often affected. We report a rare diabetic patient with pancreatic adenocarcinoma who was presented diabetic ketoacidosis and rhino-orbito-cerebral mucormycosis.Case presentation: A 66 years old man with pancreatic adenocarcinoma and type 2 diabetes mellitus was presented diabetic ketoacidosis and severe infection of the facial sinuses, orbita, and ...

ea0049ep604 | Diabetes therapy | ECE2017

Intralesional epidermal growth factor treatment on diabetic foot ulcers

Cifci Aydin , Oktas Birhan , Durmaz Senay Arikan , Gungunes Askin , Karahan Irfan , Sarak Taner

Objective: Treatment of diabetic foot ulcer is complex and difficult. Blood glucose regulation, debridment and surgical revascularization are used in management of diabetic foot ulcer. Intralesional Epidermal Growth Factor (EGF) is a new treatment approach for diabetic foot ulcer. We report our experience with eight patients with diabetic foot ulcer who were treated by intralesional EGF.Patients and methods: A total of eight patients whose diabetic foot ...

ea0049ep683 | Obesity | ECE2017

Discussion with cases: Could we achieve the goal with non-surgical treatments in morbid obese patients?

Cifci Aydin , Durmaz Senay Arikan , Gungunes Askin , Karahan Irfan , Yalcin Selim , Ozdemir Kubra

Objective: Diet, lifestyle changes, medical agents and surgical approaches are treatment options in obese patients. We reported two morbid obese patients who lost 25 and 21% of their previous weight respectively with only lifestyle changes and orlistat therapy.Case 1: Forty nine year-old woman had type 2 diabetes mellitus for 20 years. She took premix insulin twice a day. Her height was 157 cm, her weight was 120 kg, body mass index was 48.6 kg/m2</...

ea0049ep684 | Obesity | ECE2017

Body compositions in obesity may corralete the minimal change of tyhroid functions within normal range

Urun Veysel , Ureten Kemal , Utku Ozlem Gul , Gungunes Askin , Durmaz Senay Arikan

Introduction and aim: Overt thyroid dysfunction is well recognized to affect weight, but the influence of minor perturbations of thyroid function remains unclear. There is ongoing debate regarding the influence of minor changes in thyroid hormones status within the normal range and BMI. The aim of this study was to investigate the association between thyroid function within normal ranges and obesity via BMI and body compositions analyzed by bioelectrical impedance.<p class...

ea0049ep1280 | Thyroid (non-cancer) | ECE2017

Autoimmune thyroid disease may affect prognosis of breast cancer

Yalcin Selim , Cosar Ramazan , Cifci Aydin , Gungunes Askin , Durmaz Senay Arikan

Aim and objective: The aims of this study were to determine the incidence of breast cancer molecular subgroups, to investigate the relationship between autoimmune thyroid disease and prognostic and predictive factors in patients who were diagnosed with breast cancer.Materials and methods: One hundred one patients who were followed up with the diagnosis of breast cancer at our Endocrinology and Medical Oncology Departments were included. Patients are divi...

ea0041ep90 | Adrenal medulla | ECE2016

A case of ectopic Cushing syndrome due to pheocromositoma

Gungunes Askin , Durmaz Senay Arikan , Cifci Aydin , Erden Esra , Tas Merve , Yalcin Selim

Background and aim: Pheochromocytoma, is a catecholamine-producing tumor, may rarely secrete other hormones such as adrenocorticotropic hormone (ACTH). We aimed to report a rare case of ectopic cushing syndrome due to malignant pheochromocytoma.Case report: A 42-year-old man admitted to outpatient clinic with headache, irritability, vomiting, nausea, and palpitation. He had paroxysmal hypertension and urinary fractionated metanephrines were measured appr...